Search Results 681-690 of 21565 for Inhibition

1. A Study to Establish a Parkinson’s Disease (PD) Cohort using the Parkinson’s Progression Markers Initiative (PPMI) - Mayo Clinic

   eCurrent treatment with anticoagulants (e.g., coumadin, heparin, oral thrombin inhibitors) that might preclude safe completion of the lumbar puncture.

2. Research Team Uncovers Root Cause Of Multiple Myeloma Relapse

   ... inhibitors such as bortezomib or carfilzomib. Then, the team studied bone marrow biopsies from patients to further understand their results. The process ...

3. A Study to Evaluate Encorafenib Plus Cetuximab with/without Chemotherapy to Treat Metastatic Colorectal Cancer - Mayo Clinic

   ineligible to receive immune checkpoint inhibitors due to a pre-existing medical condition - Active bacterial or viral infections in 2 weeks prior to ...

4. Heartburn - Diagnosis & treatment - Mayo Clinic

   Proton pump inhibitors, which also can reduce stomach acid. Examples include esomeprazole (Nexium 24HR), lansoprazole (Prevacid 24HR) and omeprazole ...

5. A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression - Mayo Clinic

   Prior treatment with any CDK4/6 inhibitor therapy; Systemic antineoplastic therapy or any experimental therapy within 3 weeks before the first dose of study ...

6. Vardenafil (oral route) - Side effects & dosage - Mayo Clinic

   Vardenafil is used to treat men with erectile dysfunction (sexual impotence). It belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors.

7. Efficacy and Safety Trial of Apatinib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Patients With Gastric Cancer - Mayo Clinic

   ... inhibitor therapy. Known history of symptomatic congestive heart failure (New York Heart Association III-IV), symptomatic or poorly controlled cardiac ...

8. Faculty and Staff - Anticancer Drug Action Laboratory - Mayo Clinic Research

   Development of PARP Inhibitors and DDR Modifiers To Treat Ovarian Cancer · Cytotoxic Action of Novel Anti-Neoplastic Agents · Collaborators · Contact. Faculty ...

9. A Study To Explore The Renal Safety Of Visipaque Injection 320 MgI/mL In Patients With Chronic Kidney Disease - Mayo Clinic

   ... inhibition of ovulation (oral, injectable, or implantable); intrauterine device; intrauterine hormone-releasing system; bilateral tubal occlusion ...

10. Heartburn Medicines Associated with Chronic Kidney Disease Risk - Mayo Clinic News Network

    A type of heartburn medication called proton pump inhibitors (PPIs) may be linked to long-term kidney damage, according to a new study published in JAMA ...